Decreased insulitis and blood glucose levels after injection of GAD-transduced lymphocytes into NOD mice

Molecular Therapy

Volumn 6, Issue 6, 2002, Pages 701-709

  Li, Fengchun ^a   Filippova, Maria ^a   Fagoaga, Omar ^a   Nehlsen Cannarella, Sandra ^a   Escher, Alan ^a,b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Cell vaccine; Primary T lymphocytes; Retrovirus mediated gene transfer; Type 1 diabetes

Indexed keywords

ALKALINE PHOSPHATASE; CD4 ANTIGEN; CELL ANTIGEN; COMPLEMENTARY DNA; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; ISOENZYME; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC CODE; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GLUCOSE BLOOD LEVEL; IMMUNE RESPONSE; IMMUNIZATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; RETROVIRUS; SPLEEN CELL; TH2 CELL; VIRAL GENE DELIVERY SYSTEM;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0036933006     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0801     Document Type: Article

References (38)

1. Harrison, L. C., and Hafler, D. A. (2000). Antigen-specific therapy for autoimmune disease. Curr. Opin. Immunol. 12: 704-711.
2. Simone, E. A., Wegmann, D. R., and Eisenbarth, G. S. (1999). Immunologic "vaccination" for the prevention of autoimmune diabetes (type 1A). Diabetes Care 22(Suppl. 2): B7-15.
3. von Herrath, M. G., and Whitton, J. L. (2000). DNA vaccination to treat autoimmune diabetes. Ann. Med. 32: 285-292.
4. Fuchtenbusch, M., et al. (1998). Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: The Schwabing Insulin Prophylaxis Pilot Trial. Diabetologio 41: 536-541.
5. Raz, I., et al. (2001). Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): A randomised, double-blind, phase II trial. Lancet 358: 1749-1753.
6. Chaillous, L., et al. (2000). Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: A multicentre randomised controlled trial. Diabete Insuline Orale group. Lancet 356: 545-549.
7. Pozzilli, P., et al. (2000). No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group. Diabetologia 43: 1000-1004.
8. Scheen, A. J., and Philips, J. C. (2001). Insulin therapy for preventing type 1 diabetes in high-risk relatives: Negative results of the Diabetes Prevention Trial-Type 1. Rev. Med. Liege 56: 536-538.
9. Elias, D., et al. (1991). Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88: 3088-3091.
10. Clare-Salzler, M. J., Brooks, J., Chai, A., Van Herle, K., and Anderson, C. (1992). Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J. Clin. Invest. 90: 741-748.
11. Formby, B., and Shao, T. (1993). T cell vaccination against autoimmune diabetes in nonobese diabetic mice. Ann. Clin. Lab. Sci. 23: 137-147.
12. Smerdon, R. A., Peakman, M., Hussain, M. J., and Vergani, D. (1993). Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse. Immunology 80: 498-501.
13. Feili-Hariri, M., et al. (1999). Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 48: 2300-2308.
14. Shinomiya, M., Fazle Akbar, S. M., Shinomiya, H., and Onji, M. (1999). Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin. Exp. Immunol. 117: 38-43.
15. Papaccio, G., Nicoletti, F., Pisanti, F. A., Bendtzen, K., and Galdieri, M. (2000). Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology 141: 1500-1505.
16. Tisch, R., Wang, B., Atkinson, M. A., Serreze, D. V., and Friedline, R. (2001). A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice. J. Immunol. 166: 6925-6936.
17. Tian, J., et al. (2001). Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167: 1081-1089.
18. Ryu, S., Kodama, S., Ryu, K., Schoenfeld, D. A., and Faustman, D. L. (2001). Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J. Clin. Invest. 108: 63-72.
19. Ally, B. A., et al. (1995). Prevention of autoimmune disease by retroviral-mediated gene therapy. J. Immunol. 155: 5404-5408.
20. Foley, R., Tozer, R., and Wan, Y. (2001). Genetically modified dendritic cells in cancer therapy: Implications for transfusion medicine. Transfus. Med. Rev. 15: 292-304.
21. Moritani, M., et al. (1996). Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes. J. Clin. Invest. 98: 1851-1859.
22. Shaw, M. K., et al. (1997). Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185: 1711-1714.
23. Costa, G. L., et al. (2001). Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J. Immunol. 167: 2379-2387.
24. Yamamoto, et al. (2001). The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy. J. Immunol. 166: 4973-4980.
25. Nakajima, A., et al. (2001). Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J. Clin. Invest. 107: 1293-1301.
26. Liu, J., Filippova, M., Fagoaga, O., Nehlsen-Cannarella, S., and Escher, A. (1999). Intramuscular injection of plasmid DNA encoding intracellular or secreted glutamic acid decarboxylase causes decreased insulitis in the non-obese diabetic mouse. Gene Ther. Mol. Biol. 3: 197-206.
27. Filippova, M., Liu, J., and Escher, A. (2001). Effects of plasmid DNA injection on cyclophosphamide-accelerated diabetes in NOD mice. DNA Cell Biol. 20: 175-181.
28. Costa, G. L., et al. (2000). Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J. Immunol. 164: 3581-3590.
29. Serreze, D. V., et al. (2001). Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J. Immunol. 166: 1352-1359.
30. Miller, A. D., and Rosman, G. J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980-982.
31. Liu, J., Filippova, M., O'Kane, D. J., and Escher, A. (1999). Secreted Renilla luciferase: A new marker of gene expression. In Bioluminescence and Chemiluminescence: Perspectives for the 21st Century (A. Roda, L. J. Kricka, and P. Stanley, Eds.), pp. 471-474. Wiley, West Sussex, UK.
32. Berger, J., Hauber, J., Hauber, R., Geiger, R., and Cullen, B. R. (1988). Secreted placenta alkaline phosphatase: A powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66: 1-10.
33. Markowitz, D., Goff, S., and Bank, A. A. (1988). Safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62: 1120-1124.
34. Miller, A. D., and Buttimore, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6: 2895-2902.
35. Onodera, M., et al. (1997). A simple and reliable method for screening retroviral producer clones without selectable markers. Hum. Gene Ther. 8: 1189-1194.
36. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J. K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90: 8033-8037.
37. Yee, J. K., et al. (1994). A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91: 9564-9568.
38. Sambrook, J., Fritsch, E., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.